A BRIEF EXPLANATION OF THE ICCA
The ICCA is an UNINCORPORATED membership association and our democratic constitution sets out the rules under which our group is run. The entire group of full members is the ‘management committee’ and every one of them is responsible for the group’s affairs.
The Chairman is David Vanns from HI Weldrick Ltd.
Membership of the ICCA is by invitation only and member companies are from the privately owned regional multiple pharmacy sector.
Full members are proprietors and senior managers; they are innovative and committed to the sector, have much experience of pharmacy, it’s institutions, politics and evolution and have a personal interest in driving the sector forward. Member companies are based throughout Great Britain and Northern Ireland.
During times of change the occasional associate member will be invited, generally these are suppliers able to inform us of changes affecting the industry and who can benefit from our operational insights.
WHEN IT WAS FOUNDED AND WHY?
ICCA was founded in 1992 with an intention to give privately owned regional pharmacy multiples an open forum in which to debate, research and progress the local and national interests of community pharmacy.
Our 5 Key Principles;
- To co-operate on development and maintenance of high professional & commercial community pharmacy standards.
- To encourage pharmacy and healthcare bodies to improve healthcare in local communities.
- To facilitate best practice and competition between contractors in provision of community healthcare services.
- To research and develop innovation in the provision of community healthcare services.
- To network in a professional, responsible and legal way to encourage and enhance our objectives.
IS THERE A CONNECTION BETWEEN ICCA AND AIMP?
ICCA is an informal meeting, debating, study and research group. Members of ICCA are also the core founder members of AIMp but unlike AIMp the ICCA is not a political group nor is it a representative body with a formal constitution.
However, from time to time we have taken an impromptu representative position when we feel our members unanimous views are not being properly debated; such as the Pfizer/Unichem direct to pharmacy scheme when we presented formaly to MP’s, MEP’s HM Treasury and the Office of Fair Trading.